Trial Profile
Phase 2 Dose-finding, Double-blind Controlled Study of SFPP in Knee Osteoarthritis 2nd
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Esflurbiprofen (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 30 Sep 2016 New trial record